Publications
5674 Results
- Journal / Conference
- Journal of the National Cancer Institute 104(5):406-414
- Year
- 2012
- Research Committee(s)
- Breast
- PMID
- PMID22250182
- PMC
- PMC3295746
- Study Number(s)
- E1199
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial
- Journal / Conference
- Journal of Clinical Oncology 30(25):3051-3057
- Year
- 2012
- Research Committee(s)
- Breast
- PMID
- PMID2851566
- PMC
- PMC3732004
- Study Number(s)
- E1199
Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer
- Journal / Conference
- Journal of Clinical Oncology 33(20):4071-4076
- Year
- 2012
- Research Committee(s)
- Breast
- PMID
- PMID22826271
- PMC
- PMC3494835
Six cycles of doxorubicin and cyclophosphamide or paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101
- Journal / Conference
- Journal of the American Medical Association 307(13):1383-1393
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID22474202
- PMC
- PMC3442260
- Study Number(s)
- CTSU/N0147
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer
- Journal / Conference
- Expert Review of Anticancer Therapy 12(12):1591-1596
- Year
- 2012
- Research Committee(s)
- Lung
- PMID
- PMID23253224
- PMC
- Reviews are not within the scope of the Public Access Policy
- Study Number(s)
- S0003, S0124
Efficacy and toxicity differences in lung cancer populations in the era of clinical trials globaliztion: the "common arm" approach
- Journal / Conference
- Clinical Lung Cancer 13(5):321-325
- Year
- 2012
- Research Committee(s)
- Lung
- PMID
- PMID2267743
- PMC
- Reviews not within the scope of the Public Access Policy
- Study Number(s)
- S0819
Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneity
- Journal / Conference
- Journal of the American College of Surgeons 215(1):53-59
- Year
- 2012
- Research Committee(s)
- Sarcoma
- PMID
- PMID22726733
- PMC
- PMC3383609
- Study Number(s)
- CTSU/Z9000
Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence
- Journal / Conference
- Blood (ASH Annual Meeting) 120:abst 4079 (poster)
- Year
- 2012
- Research Committee(s)
- Myeloma
- Study Number(s)
- CTSU/E3A06
Phase II Trial of Initial Safety and Toxicity Prior to the Phase III Trial of Lenalidomide Versus Observation Alone in Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma (E3A06): A Trial Coordinated by the Eastern Cooperative Oncology Group
- Journal / Conference
- Cancer 118(23):5937-46
- Year
- 2012
- Research Committee(s)
- Breast
- PMID
- PMID22926690
- PMC
- PMC3586227
- Study Number(s)
- E1199
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer
- Journal / Conference
- Journal of Clinical Oncology 30(suppl; abstr 4500); oral; ASCO Annual Meeting (June 1-5, 2012, Chicago, IL)
- Year
- 2012
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/E2805